发布求助
文献互助 智能选刊 最新文献

Beitrage zur Infusionstherapie = Contributions to infusion therapy最新文献

筛选
英文 中文
[Presentation of autologous blood donation in a large clinic]. [大型诊所自体献血的介绍]。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
B Lubitz, D Roos, P Kühnl
{"title":"[Presentation of autologous blood donation in a large clinic].","authors":"B Lubitz, D Roos, P Kühnl","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"29 ","pages":"251-60"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18694775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of 7 anti-hepatitis C virus enzyme immunoassays of the 2nd generation in blood donation services]. 7种第二代丙型肝炎病毒酶免疫检测在献血服务中的比较
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
C Gabriel, B Blauhut
{"title":"[Comparison of 7 anti-hepatitis C virus enzyme immunoassays of the 2nd generation in blood donation services].","authors":"C Gabriel,&nbsp;B Blauhut","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Seven enzyme-linked immunosorbent assays for the detection of antibodies to hepatitis C virus were compared: three assays with synthetic peptides in the coating showed overproportional higher rates of initial reactive and also the highest rate of so-called false-positive results in comparison with the RIBA assay. One assay with synthetic peptides had also the most false-negative results in comparison with RIBA-reactive results. The best results are found in assays with recombinant proteins, in which proteins derived from the NS-4 region are present.</p>","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"16-20"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18697718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Initial experiences with routine use of the AS-104 cell separator in a single needle procedure]. [在单针程序中常规使用AS-104细胞分离器的初步经验]。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
T Zeiler, V Weisbach, J Zingsem, R Zimmermann, R Eckstein
{"title":"[Initial experiences with routine use of the AS-104 cell separator in a single needle procedure].","authors":"T Zeiler,&nbsp;V Weisbach,&nbsp;J Zingsem,&nbsp;R Zimmermann,&nbsp;R Eckstein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Since 1992, the Fresenius cell separator AS-104 offers a single-needle option. The authors present data on their first experience with this new single-needle thrombocytapheresis system.</p>","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"100-3"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18695518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recombinant antibodies in serologic diagnosis]. 重组抗体在血清学诊断中的应用
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
A Wölpl, M Cardoso, K Siemoneit, K Koerner, B Kubanek
{"title":"[Recombinant antibodies in serologic diagnosis].","authors":"A Wölpl,&nbsp;M Cardoso,&nbsp;K Siemoneit,&nbsp;K Koerner,&nbsp;B Kubanek","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In this paper we discuss the value of a new methodology for the production of monoclonal antibodies by recombinant techniques. This approach is especially useful for human monoclonal antibodies due to instability of human antibody-producing cell lines. As an example, we present a recombinant human antibody to the hepatitis C virus (HCV) core protein.</p>","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"147-51"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18696024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical applications and contraindications of mechanical autologous blood transfusion]. 机械自体输血的临床应用及禁忌。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
H H Mehrkens
{"title":"[Clinical applications and contraindications of mechanical autologous blood transfusion].","authors":"H H Mehrkens","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"29 ","pages":"146-57"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18693714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Indications and contraindications of plasmapheresis and autologous blood donation]. 血浆置换和自体献血的适应症和禁忌症。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
I Linde
{"title":"[Indications and contraindications of plasmapheresis and autologous blood donation].","authors":"I Linde","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"29 ","pages":"158-62"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18693715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Critical limits of hemodilution: theoretical principles]. [血液稀释临界极限:理论原理]。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
R Zander
{"title":"[Critical limits of hemodilution: theoretical principles].","authors":"R Zander","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>For daily clinical practice an isovolemic hemodilution down to an arterial O2 content of 10 ml/dl, corresponding to a hemoglobin content of 7.5 g/dl or a hematocrit value of 22.5%, is described as a tolerable value, as long as normovolemia and normoxia (no disturbances of lung function) are guaranteed and local restrictions in perfusion (coronary or cerebral sclerosis) are excluded. This value is not derived from the mixed venous O2 status but from the situation of the myocardium as the main limiting organ for anemic hypoxemia. Compensation of anemia is regulated hemodynamically: First, by an increase in stroke volume; secondary, by an increase in heart frequency and, tertiary, by an increase in venous utilization. The last may reach 100% without any restrictions from the so-called critical mixed venous pO2 as a possible limiting factor for hemodilution.</p>","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"29 ","pages":"51-69"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18694779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Indications and contraindications of hemodilution]. [血液稀释的适应症和禁忌症]。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
B von Bormann, M Friedrich
{"title":"[Indications and contraindications of hemodilution].","authors":"B von Bormann,&nbsp;M Friedrich","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"29 ","pages":"97-117"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18694782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of homologous blood saving measures in Germany (former German states)--results of a national survey]. [在德国(前德国各州)使用同源血液保存措施——一项全国性调查的结果]。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
G Singbartl, W Schleinzer, M Becker, C Frankenberg
{"title":"[Use of homologous blood saving measures in Germany (former German states)--results of a national survey].","authors":"G Singbartl,&nbsp;W Schleinzer,&nbsp;M Becker,&nbsp;C Frankenberg","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"29 ","pages":"26-39"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18694776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recombinant plasma proteins for therapeutic use--status and developmental trends]. [用于治疗的重组血浆蛋白——现状和发展趋势]。
Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01
H Storch
{"title":"[Recombinant plasma proteins for therapeutic use--status and developmental trends].","authors":"H Storch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The enormous progress made in biotechnology and purification of plasma proteins (pp) and the demands to avoid risks of transmitting HIV, hepatitis and other virus infections by these have resulted in the development of numerous recombinant human (rh) pp, which are now about to be used as replacement therapy in transfusion medicine. Human rh albumin has been used in clinical trials last year, a competition to serum albumin can be expected in the next time. During the last decade, the genes or cDNA have been cloned and characterized for all relevant pp involved in blood coagulation. Beside the rh factor VIII (rh FVIII) which has been introduced clinically in 1991, the rh FVIIa is under investigation in patients with hemophilia A and inhibitors. After establishing of rhFIX in triple transgenic mice, the industrial potential will be evaluated in terms of scale up culturing and production. The valuation of advantages and drawbacks of the current rh pp in comparison to conventional pp will have to be determined in the last decade of our century.</p>","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"31-7"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18695908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书